Navigation Links
Kayentis, the Leading Provider of the Unique "Paper-Based e-Trial" Solution, has been Retained for Six New Clinical Studies in the US Market

Kayentis, the global leader of digital pen and paper technology and the unique provider of "paper-based e-trial" solution, today announced that it has been retained for six new clinical studies conducted in the US, therefore continuing and strengthening its expansion in North America.

Philadelphia, PA / Gif sur Yvette, France (PRWEB) September 22, 2009 -- Kayentis offers Clin'Form, the optimal paper-based e-data capture solution for clinical trials. Clin'Form combines the best that the physical and the digital worlds have to offer. It is the easiest and most reliable data collection method for both patients and physicians (pen & paper), resulting in the highest quality of data captured. These benefits are combined with all the advantages of electronic data management (real-time access, data sharing, audit trail functionalities, alerts, etc.); while providing accurate timestamps and significantly streamlining clinical trial costs.

Six US pharmaceutical companies have retained Clin'Form to run their clinical studies, involving investigators and patients (CRF and PRO). "We are much honored to have been retained by our new sponsors. Clin'Form, our Digital Pen and Paper based data capture solution, helps them improve the quality of the data captured and significantly reduces the steps required for the deployment of a study - and in doing so simultaneously saves time and costs dramatically" comments Guy Maestre, Kayentis Vice President, North American Operations. "It provides a decisive advantage for life sciences companies in the implementation of their clinical trials while end-users (investigators, CRAs, patients) benefit from a very natural way to capture clinical data."

Clin'Form has been successfully deployed in studies conducted in more than 40 countries, in over forty different languages, and involving over 50 000 patients across all continents.

Kayentis provides software solutions dedicated to each stage of a drug's life cycle development. It offers key solutions to collect, display, share and archive information and clinical data. Kayentis Clin'Form solution, enabling Anoto functionality, is the optimal paper-based e-data capture solution for clinical trials.
Kayentis is a member of Pennsylvania BIO and BIO New Jersey. Kayentis is an Anoto Platinum Partner, an Oracle Partner and an HP Solution Business Partner.

To discover more about this unique solution please visit


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
(Date:11/25/2015)... ... ... Today, Mothers Against Drunk Driving (MADD) learned that the number of ... time since 2011. In 2014, there were 9,967 fatalities involving an alcohol impaired driver, ... Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in 2014. Drunk ...
(Date:11/25/2015)... ... November 25, 2015 , ... In honor ... Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension (PH) ... nominated by the public, will receive special recognition throughout 2016 as part of ...
(Date:11/25/2015)... ... 25, 2015 , ... Privately owned Contract Development and Manufacturing ... its current state of the art research, development and manufacturing facility outside of ... manufacturing capacity as well as to support its clients’ growing research and development ...
(Date:11/25/2015)... ... November 25, 2015 , ... Many people know of ... weight gain, cold hands, and dry skin. But many people who find their cholesterol ... exercise regimen instead of their thyroid, especially if they don’t have any of the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in ... involving adult stem cell therapies to patients with chronic degenerative medical conditions. Now, ... a Registered Trademark (RTM). , Organizations are required to hold a registered trademark ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Nov. 25, 2015  Mindray Medical ... MR ), a leading developer, ... worldwide, today announced that it will ... of shareholders at the Company,s Hong Kong office ... Prince Edward West Road, Mongkok KL, Hong ...
(Date:11/25/2015)... , November 25, 2015 /PRNewswire/ ... announced the addition of the  "Global ...  report to their offering.  ... the addition of the  "Global Drug ...  report to their offering.  --> ...
Breaking Medicine Technology: